Publications

  1. Dungan K, Craven TE, Soe K, Wright JT Jr, Basile J, Haley WE, Kressin NR, Rani U, Tamariz L, Whittle J, Wiggers A, Osei K. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab. 2017 Oct 12 [Epub ahead of print]
    View PubMed
  2. Beddhu S, Chertow GM, Cheung AK, Cushman WC, Rahman M, Greene T, Wei G, Campbell RC, Conroy M, Freedman BI, Haley WE, Horwitz EJ, Kitzman DW, Lash J, Papademetriou V, Pisoni R, Riessen E, Rosendorff C, Watnick SG, Whittle J, Whelton PK, SPRINT Research Group. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared to Standard Blood Pressure Control. Circulation. 2017 Oct 11 [Epub ahead of print]
    View PubMed
  3. Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, Coker L, Haley WE, Killeen AA, Kimmel PL, Lerner AJ, Oparil S, Saklayen MG, Slinin YM, Wright CB, Williamson JD, Kurella Tamura M, SPRINT Study Research Group. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2017 Sep; 70 (3):357-367 Epub 2017 June 09
    View PubMed
  4. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J, SPRINT Research Group. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep; 28 (9):2812-2823 Epub 2017 June 22
    View PubMed
  5. Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC Jr, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017 Jan; 69 (1):42-50 Epub 2016 Nov 14
    View PubMed
  6. Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD. Kidney Function After the First Kidney Stone Event. Mayo Clin Proc. 2016 Dec; 91: (12)1744-1752.
    View PubMed
  7. Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT Jr, Yeboah J, SPRINT Study Research Group. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens. 2016 Nov; 10 (11):847-856 Epub 2016 Aug 26
    View PubMed
  8. Haley WE, Gilbert ON, Riley RF, Newman JC, Roumie CL, Whittle J, Kronish IM, Tamariz L, Wiggers A, Morisky DE, Conroy MB, Kovalik E, Kressin NR, Muntner P, Goff DC Jr, SPRINT Study Research Group. The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016 Nov; 10 (11):857-864.e2 Epub 2016 Sept 07
    View PubMed
  9. Cernigliaro JG, Haley WE, Adolphson DP, Jepperson MA, Crook JE, Thomas CS, Parker AS. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol. Clin Imaging. 2016 Sep-Oct; 40: (5)902-6.
    View PubMed
  10. Porter IE, Haley WH. Key Points in Kidney Stones Northeast Florida Medicine Journal.2016;67:(2)11-15.
  11. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM, SPRINT Research Group. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged >/=75 Years: A Randomized Clinical Trial. JAMA. 2016 Jun 28; 315 (24):2673-82
    View PubMed
  12. Ibrahim, Cernigliaro JG, Pooley RA, Bridges MD, Giesbrandt JG, Williams JC, Haley WE. Detection of different kidney stone types: an ex vivo comparison of ultrashort echo time MRI to reference standard CT. Clin Imaging. 2016 Jan-Feb; 40: (1)90-5.
    View PubMed
  13. Haley WE, Gilbert ON, Riley RF, Newman JC, Roumie CL, Whittle J, Kronish IM, Tamariz L, Wiggers A, Morisky DE, Conroy MB, Kovalik E, Kressin NR, Muntner P, Goff DC Jr. The association between self-reported medication adherence scores and systolic blood pressure control: a SPRINT baseline data study Journal of the American Society of Hypertension. 2016; 10: (11)857-864.e2.
  14. Ibrahim EH, Cernigliaro JG, Bridges MD, Pooley RA, Haley WE. The Capabilities and Limitations of Clinical Magnetic Resonance Imaging for Detecting Kidney Stones: A Retrospective Study. Int J Biomed Imaging. 2016; 2016:4935656.
    View PubMed
  15. Ibrahim, Cernigliaro JG, Pooley RA, Williams JC, Haley WE. Motion artifacts in kidney stone imaging using single-source and dual-source dual-energy CT scanners: a phantom study. Abdom Imaging. 2015 Oct; 40: (8)3161-7.
    View PubMed
  16. Beau J, Haley W, Ibrahim E, Parker A, Coyle C, Broderick G. Prevalence of nephrolithiasis among patients with vascular erectile dysfunction. Sex Med. 2015 April:11:201-2.
  17. Jepperson MA, Cernigliaro JG, Ibrahim, Morin RL, Haley WE, Thiel DD. In vivo comparison of radiation exposure of dual-energy CT versus low-dose CT versus standard CT for imaging urinary calculi. J Endourol. 2015 Feb; 29: (2)141-6.
    View PubMed
  18. Haley WE, Beckrich AL, Sayre J, McNeil R, Fumo P, Rao VM, Lerma EV. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis. 2015 Jan; 65(1):67-79. Epub 2014 Aug 30.
    View PubMed
  19. Ibrahim ES, Pooley R, Cernigliaro J, Bridges M, Williams J, Haley W. Motion artifacts in kidney stone imaging using dual-energy CT. A phantom study comparing single-source and dual-source scanners. Proceedings - International Symposium on Biomedical Imaging. 2015; 2015-July:1159-62.
  20. Ibrahim ES, Pooley R, Cernigliaro J, Bridges M, Giesbrandt J, Williams J, Haley W. In vitro imaging of kidney stones using ultra-short echo-time magnetic resonance. Proceedings - International Symposium on Biomedical Imaging. 2015; 2015-July:1466-9.
  21. Haley WE, Ibrahim, Qu M, Cernigliaro JG, Goldfarb DS, McCollough CH. The Clinical Impact of Accurate Cystine Calculi Characterization Using Dual-Energy Computed Tomography. Case Rep Radiol. 2015; 2015:801021.
    View PubMed
  22. Jepperson MA, Ibrahim, Taylor A, Cernigliaro JG, Haley WE, Thiel DD. Accuracy and efficiency of determining urinary calculi composition using dual-energy computed tomography compared with Hounsfield unit measurements for practicing physicians. Urology. 2014 Sep; 84: (3)561-4.
    View PubMed
  23. Ibrahim, Haley WE, Jepperson MA, Wehle MJ, Cernigliaro JG. Characterization of ureteral stents by dual-energy computed tomography: Clinical implications. World J Radiol. 2014 Aug 28; 6: (8)625-8.
    View PubMed
  24. Hutchinson R, Parker AS, Arnold M, Bowers SP, Haley WE, Diehl N, Stone R, Lynch SA, Smith CD, Thiel DD. Prospective evaluation of 24-hour urine profiles following bariatric surgery in a modern comprehensive care bariatric clinic. Clin Nephrol. 2014 May; 81(5):331-7.
    View PubMed
  25. Jepperson M, Theil D, Ibrahim E, Haley W. In vivo radiation exposure due to urinary calculi imaging: Single source versus low dose CT using vs Dual source DECT. SESAUA. 2014 March.
  26. Jepperson M, Theil D, Ibrahim E, Taylor A, Cernigliaro J, Haley W. Accuracy and efficiency of determining stone composition utilizing imaging DECT compared to standard HU. SESAUA. 2014 March.
  27. Jepperson MA, Thiel DD, Cernigliaro JG, Broderick GA, Haley WE. Case series demonstrating the clinical utility of dual energy computed tomography in patients requiring stents for urinary calculi. Can J Urol. 2014 Feb; 21: (1)7166-70.
    View PubMed
  28. Ibrahim ESH, Pooley RA, Bridges MD, Cernigliaro JG, Haley WE. Kidney stone imaging with 3D ultra-short echo time (UTE) magnetic resonance imaging. A phantom study. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2014. 2014:2356-9.
  29. Ibrahim E, Pooley R, Bridges M, Cernigliaro J, Haley W. Volumetric ultra short echo time MR imaging of kidney stones. RSNA. 2014.
  30. Jepperson M, Cernigliaro J, Haley W. Contrast-induced nephropathy in outpatients with pre-existing renal disease. RSNA. 2014.
  31. Jepperson MA, Cernigliaro JG, Sella D, Ibrahim E, Thiel DD, Leng S, Haley WE. Dual-energy CT for the evaluation of urinary calculi: image interpretation, pitfalls and stone mimics. Clin Radiol. 2013 Dec; 68: (12)e707-14.
    View PubMed
  32. Elliott MR, Soto Soto JM, Haley WE, Fitzpatrick PM, Dwyer JP. Labile hypertension: characteristics of a referred cohort. Clin Exp Hypertens. 2013; 35(3):207-12. Epub 2012 Aug 23.
    View PubMed
  33. Ibrahim, Haley WE, Jepperson MA, Thiel DD, Wehle MJ, Cernigliaro JG. Three-dimensional dual-energy computed tomography for enhancing stonestent contrasting and stone visualization in urolithiasis. Case Rep Urol. 2013; 2013:646087.
    View PubMed
  34. Jepperson MA, Thiel DD, Cernigliaro JG, Broderick GA, Parker AS, Haley WE. Determination of ureter stent appearance on dual-energy computed tomography scan. Urology. 2012 Nov; 80: (5)986-9.
    View PubMed
  35. Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC. Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clin Nephrol. 2012 Apr; 77(4):290-5.
    View PubMed
  36. Soto Soto J, Phillips M, Cernigliaro J, Haley W. Renal autotransplantation for iatrogenic high-grade ureteric stricture. Case Rep Urol. 2012; 2012:259527. Epub 2012 Dec 4.
    View PubMed
  37. Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol. 2011 Sep; 6: (9)2289-95.
    View PubMed
  38. Thiel DD, Brisson TE, Heckman MG, Arnold M, Haley W, Khambhati J, Wehle MJ, Igel TC, Parker AS. Evaluation of pancreatic damage after extracorporeal shock wave lithotripsy, percutaneous stone surgery, and ureteroscopy. Urology. 2011 Jun; 77(6):1288-91. Epub 2011 Jan 07.
    View PubMed
  39. Thiel DD, Brisson TE, Heckman MG, Arnold M, Haley WE, Khambhati J, Wehle MJ, Igel TC, Parker AS. Evaluation of pancreatic damage after extracorporeal shock wave lithotripsy, percutaneous stone surgery, and ureteroscopy. J Endourol. 2011; 25(11):1690-1.
  40. Patwardhan MB, Matchar DB, Samsa GP, Haley WE. Opportunities for improving management of advanced chronic kidney disease. Am J Med Qual. 2008 May-Jun; 23(3):184-92.
    View PubMed
  41. Patwardhan MB, Matchar DB, Samsa GP, Haley WE. Utility of the advanced chronic kidney disease patient management tools: case studies. Am J Med Qual. 2008 Mar-Apr; 23(2):105-14. Epub 2008 Feb 27.
    View PubMed
  42. Patwardhan MB, Matchar DB, Haley WE, Samsa, GP. Non-Nephrologist and Nephrologist Perspectives on Implementing a Chronic Kidney Disease Guideline. Journal for Healthcare Quality.2007;29:
  43. Patwardhan MB, Samsa GP, Matchar DB, Haley WE. Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. Clin J Am Soc Nephrol. 2007 Mar; 2(2):277-83. Epub 2007 Jan 03.
    View PubMed
  44. Matchar DB, Patwardhan MB, Samsa GP, Haley WE. Facilitated process improvement: an approach to the seamless linkage between evidence and practice in CKD. Am J Kidney Dis. 2006 Mar; 47(3):528-38.
    View PubMed
  45. Haley WE. The RPA Advanced Chronic Kidney Disease Management Toolkit. Improving management and care of advanced chronic kidney disease patients. Renal Physicians Association Available at http//www.renalmd.org/ Accessed March 5, 2006. 2005;
    View PubMed
  46. Ejaz AA, Haley WE, Wasiluk A, Meschia JF, Fitzpatrick PM. Characteristics of 100 consecutive patients presenting with orthostatic hypotension. Mayo Clin Proc. 2004 Jul; 79(7):890-4.
    View PubMed
  47. Haley WE. The Renal Physicians Association Advanced Chronic Kidney Disease Clinical Practice Guidelines. Journal of The Academia Nacional de Medicina. 2003 May; 2(3):23-32.
  48. Bolton WK, Owen WF, Coburn J, Haley WE, et al. Appropriate patient preparation for renal replacement therapy. RPA Clinical Practice Guideline #3. Renal Physicians Association Available at http//www.renalmd.org/ Accessed March 5, 2006. 2002 Oct;
  49. Haley WE, Bennett W. Principles for drug prescribing in ESRD patients. Position Paper. Renal Physicians Association Available at http//www.renalmd.org/ Accessed March 5, 2006. 2002 Feb;
  50. Haley WE, Kliger A, Owen WF, Matchar D. Integrating public policy and socioeconomic issues in the process and methodology for clinical practice guidelines. Position Paper. Renal Physicians Association Available at http//www.renalmd.org/ Accessed March 5, 2006. 2001 Oct;
  51. Mancia G, Omboni S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens. 2001 Oct; 19(10):1755-63.
    View PubMed
  52. Zabalgoitia M, Rahman SN, Haley WE, Yarows S, Krause L, Anderson LC, Oraby MA, Amarena J. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study). Am J Cardiol. 2001 Sep 1; 88(5):521-5.
    View PubMed
  53. Ejaz AA, Fitzpatrick PM, Haley WE, Wasiluk A, Durkin AJ, Zachariah PK. Amlodipine besylate induced acute interstitial nephritis. Nephron. 2000 Aug; 85 (4):354-6
    View PubMed
  54. Kliger AS, Haley WE. Clinical practice guidelines in end-stage renal disease: a strategy for implementation. J Am Soc Nephrol. 1999 Apr; 10(4):872-7.
    View PubMed
  55. Zabalgoitia M, Rahman NU, Haley WE, Mercado R, Yunis C, Lucas C, Yarows S, Krause L, Amarena J. Comparison in systemic hypertension of left ventricular mass and geometry with systolic and diastolic function in patients less-than-65 to greater-than-or-equal-to-65 years of age. Am J Cardiol. 1998 Sep 1; 82(5):604-608.
    View PubMed
  56. Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, Butt AR, Rahman SN, Hansson L. Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension. 1998 Apr; 31(4):1014-20.
    View PubMed
  57. Mailloux LM, Haley WE. In-depth Review: Hypertension in the ESRD Patient: Pathophysiology, Therapy, Outcomes, and Future Directions. AJKD. 1998; 32(5):705-19.
    View PubMed
  58. McClellan WM, Soucie JM, Krisher J, Carauna R, Haley WE, Farmer C. Improving the adequacy of hemodialysis of patients in the medicare end-stage renal disease program: a case study of the ESRD Core Indicators Project. AJKD. 1998; 31:584-92.
    View PubMed
  59. Zabalgoitia M, Rahman NU, Haley WE, et al. Impact of ethnicity on left ventricular mass and relative wall thickness in essential hypertension. Am J Cardiol. 1998; 81(4):412-7.
    View PubMed
  60. Haley WE, Henrich W. Credentialing in Nephrology. RPA/ASN Position Paper, Renal Physicians Association and American Society of Nephrology. Available at http//www.renalmd.org/Accessed 3/5/2006. 1998;
  61. Zabalgoitia M, Rahman NU, Haley WE, et al. Disparity between diastolic mitral flow characteristics and left ventricular mass in essential hypertension. Am J Cardiol. 1997; 79:1255-8.
    View PubMed
  62. Zabalgoitia M, Rahman NU, Haley WE, et al. Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women >50 years of age with systemic hypertension. Am J Cardiol. 1997; 80:648-51.
    View PubMed
  63. Zabalgoitia M, Rahman NU, Haley WE, et al. Role of left ventricular hypertrophy in diastolic dysfunction in aged hypertensive patients. J Hypertension. 1997; 15:1175-9.
  64. Haley WE. Process and Methodology for the evaluation of clinical practice guidelines. RPA/ASN Position Paper, Renal Physicians Association and American Society of Nephrology. Available at http//www.renalmd.org/Accessed March 5, 2006. 1997;
  65. Zabalgoitia M, Rahman NU, Haley WE, et al. Left ventricular mass and function in treated and untreated primary hypertension. Am J Cardiol. 1996; 78: 838-40.
  66. Zabalgoitia M, Rahman NU, Haley WE, et al. Gender dimorphism in cardiac adaptation to hypertension is unveiled by prior treatment and efficacy. Am J Cardiol. 1996; 78:838-40.
    View PubMed
  67. Haley WE, Mailloux LM. Hypertension as a Core Indicator for ESRD. RPA/ASN Position Paper, Renal Physicians Association and American Society of Nephrology. Available at http//www.renalmd.org/Accessed 3/5/2006. 1996 Jul;
  68. Haley WE, Garfinkel HB, Brunt JR, Williams AV. Effect of sodium intake on adaptation to chronic potassium loading. Mineral and Electrolyte Metabolism. 1980; 3:302-11.
  69. Haley WE, Galloway, Glassman. Acute Glomerulonephritis. American Journal of Medical Technology. 1979; 45(8):694-700.
    View PubMed
  70. Haley WE, Johnson JW. Measurement of urinary renin activity by radio- immunoassay: sequential studies in acute renal failure in man. Nephron. 1978; 20:273-85.
    View PubMed